Logo Asphalion
Resources Hub

SPIOMET4HEALTH project | Clinical trials

PCOS affects between 5 and 10% of women of reproductive age and can cause increased body hair and acne, irregular menstrual periods, and fertility problems. It is the most common endocrine disorder in women of reproductive age but is still one of the most unknown pathologies among the general population. It can also lead to the development of other diseases such as type 2 diabetes, cancer before menopause, and anxiety or depression, which can greatly impact the quality of life for women affected by the condition.

PCOS affects between 5 and 10% of women of reproductive age and can cause increased body hair and acne, irregular menstrual periods, and fertility problems. It is the most common endocrine disorder in women of reproductive age but is still one of the most unknown pathologies among the general population. It can also lead to the development of other diseases such as type 2 diabetes, cancer before menopause, and anxiety or depression, which can greatly impact the quality of life for women affected by the condition.
April 17, 2023
|

You can now participate in the clinical trial for polycystic ovary syndrome (PCOS) in Norway, Denmark, Italy, Austria, Turkey and Spain!

The clinical trials is aimed at girls and women with Polycystic Ovary Syndrome (PCOS) and who fulfill the following criteria:

✔ 12-24 years

✔ Irregular periods

✔ High amount of body hair

Spiomet4Health aims to provide a novel treatment for adolescent girls and young adult women with Polycystic Ovary Syndrome (PCOS). At ASPHALION, we are proud regulatory partners of this EU-funded HORIZON project. We are committed to improving women’s health!

➥ Come join Spiomet4Health clinicaltrials!

ℹ Further information ⬇

 

You can now participate in the clinical trial for Polycystic Ovary Syndrome (PCOS) in Norway, Denmark, Italy, Austria, Turkey and Spain

Search News & Events

  • Search

  • Filter by category

Share

Related news and events

In2Sight | 4th annual meeting 3RS congress

September 14, 2023

At ASPHALION, we are part of the IN2SIGHT consortium, an EU-funded project, and we are delighted to be currently participating in the 4th annual meeting

Course | Regulatory aspects of vaccine development

September 7, 2023

TRANSVAC2 supported innovation for both prophylactic and therapeutic vaccine development by providing high-quality technical services across four different service platforms: Technology (for process development and GMP production), Immunocorrelates & Systems Biology, Animal models, and support for Clinical Trials. TRANSVAC also offered training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics.

ASPHALION HIGHLIGHTS Q2 2023

July 20, 2023

A lot of things have happened during these past three months. We received an award from AEFI as most engaged Company with its employees’ traning;

More news & Events

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Logo Asphalion
Free Meeting

Services

Follow us!

Memberships & Partnerships

Catalonia Trade & Investment - ACCIÓ
Team PRRC

Quality Management System

© Asphalion

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule Now!
Schedule a meeting